Former Waymo Legal Executive David Tressler Joins 6K as Chief Legal Officer
The new appointment supports the acceleration of 6K’s global expansion and commercial growth.
Codetta Bio Appoints New Vice President of Product Management to Lead Commercial Strategy
Jeremy Lambert brings 20 years of experience in life sciences product development and commercialization from Caliper Life Sciences, PerkinElmer, and Quanterix.
South 8 Technologies Secures Strategic Investment from Lockheed Martin Ventures
Funding will support the commercialization of LiGas®, South 8’s liquefied gas electrolyte technology that’s a safer, higher performance alternative to standard liquid electrolytes
Patent Awarded for Primary Template-Directed Amplification, Further Strengthening BioSkryb Genomics’ Core Technologies
The product solution combines HP’s new D100 Single Cell Dispenser with BioSkryb’s ResolveDNA® technology to enable the investigation of large single-cell genomics studies with unprecedented coverage and accuracy
BioFlyte Raises $5.4M in Series B Financing to Protect Critical Infrastructure from Airborne Biothreats
The product solution combines HP’s new D100 Single Cell Dispenser with BioSkryb’s ResolveDNA® technology to enable the investigation of large single-cell genomics studies with unprecedented coverage and accuracy
NUBURU Announces Contract With NASA for Next-generation Blue Laser Space Technology
The product solution combines HP’s new D100 Single Cell Dispenser with BioSkryb’s ResolveDNA® technology to enable the investigation of large single-cell genomics studies with unprecedented coverage and accuracy
Excision BioTherapeutics Receives FDA Fast Track Designation for EBT-101, a First-in-Class CRISPR-Based Gene Therapy Candidate to Functionally Cure HIV-1
EBT-101 is a potentially curative, one-time CRISPR-based treatment which makes two cuts in integrated retroviral DNA to remove large portions of the HIV genome and prevent HIV from escaping and reproducing
Excision’s ongoing Phase 1/2 trial is the first clinical evaluation of a CRISPR-based therapy targeting an infectious disease using a multiplexed in vivo gene editing approach
HIV-1 affects 38 million people worldwide, including 1.1 million in the US, with no available cures
NTx Partners with Ginkgo Bioworks; Awarded DARPA Contract to Reimagine the Manufacturing of Complex Therapeutic Proteins
The 4-year contract is worth up to $18 million to reimagine how to manufacture complex therapeutic proteins.
BIOKÉ and BioSkryb Genomics announce a distribution agreement for the Benelux and Nordic countries
BIOKÉ and BioSkryb Genomics announce a distribution agreement for the Benelux and Nordic countries
e-Zinc Appoints Accomplished Financial Executive Rhonda Landers as CFO
Ms. Landers completes e-Zinc’s executive team of seasoned energy technology industry leaders who will drive the company’s next stage of growth.